Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Baxter
Medtronic
Merck
Mallinckrodt

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

CHILDREN'S ADVIL ALLERGY SINUS Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Children's Advil Allergy Sinus patents expire, and what generic alternatives are available?

Children's Advil Allergy Sinus is a drug marketed by Glaxosmithkline and is included in one NDA. There is one patent protecting this drug.

This drug has nine patent family members in eight countries.

The generic ingredient in CHILDREN'S ADVIL ALLERGY SINUS is chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Children's Advil Allergy Sinus

Children's Advil Allergy Sinus was eligible for patent challenges on December 31, 1968.

Indicators of Generic Entry

< Available with Subscription >

  Start Trial

Summary for CHILDREN'S ADVIL ALLERGY SINUS
International Patents:9
US Patents:1
Applicants:1
NDAs:1
Clinical Trials: 7,543
Formulation / Manufacturing:see details
DailyMed Link:CHILDREN'S ADVIL ALLERGY SINUS at DailyMed
Drug patent expirations by year for CHILDREN'S ADVIL ALLERGY SINUS
Recent Clinical Trials for CHILDREN'S ADVIL ALLERGY SINUS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Douglas FraserPhase 3
Y-mAbs TherapeuticsPhase 1/Phase 2
Global Alliance for TB Drug DevelopmentPhase 1

See all CHILDREN'S ADVIL ALLERGY SINUS clinical trials

US Patents and Regulatory Information for CHILDREN'S ADVIL ALLERGY SINUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline CHILDREN'S ADVIL ALLERGY SINUS chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021587-001 Feb 24, 2004 OTC Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKinsey
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.